201 related articles for article (PubMed ID: 31423241)
1. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway.
Wang X; Wang X
Oncol Lett; 2019 Aug; 18(2):1745-1754. PubMed ID: 31423241
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway.
He P; Xiong G; Guo W; Jiang G; Li Y; Li H
Oncol Lett; 2020 Oct; 20(4):97. PubMed ID: 32831916
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt/β-catenin signaling pathway.
Zhao C; Qiao C; Zong L; Chen Y
Oncol Lett; 2018 Oct; 16(4):4600-4606. PubMed ID: 30214594
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells.
Wang B; Liu M; Zhuang R; Jiang J; Gao J; Wang H; Chen H; Zhang Z; Kuang Y; Li P
Oncol Lett; 2018 Mar; 15(3):3369-3375. PubMed ID: 29435081
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the
Yang C; Li F; Zhou W; Huang J
J Int Med Res; 2021 May; 49(5):3000605211019938. PubMed ID: 34057837
[TBL] [Abstract][Full Text] [Related]
7. Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway.
Wang BD; Jiang J; Liu MM; Zhuang RJ; Wang H; Li PL
Int J Clin Exp Pathol; 2017; 10(12):11771-11778. PubMed ID: 31966540
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting proliferation and metastasis of osteosarcoma cells by downregulation of long non-coding RNA colon cancer-associated transcript 2 targeting microRNA-143.
Bi F; Chen C; Fu J; Yu L; Geng J
Oncol Lett; 2021 Apr; 21(4):265. PubMed ID: 33664828
[TBL] [Abstract][Full Text] [Related]
11. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.
Ma Y; Hu X; Shang C; Zhong M; Guo Y
Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CCAT2 promotes proliferation and metastasis in non-small cell lung cancer through the Wnt pathway.
Li J; Liu Y; Li P; Guo Y; Liu Y; Ren Y
Int J Clin Exp Pathol; 2017; 10(7):7983-7990. PubMed ID: 31966650
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling.
Lin S; Wang H; Yang W; Wang A; Geng C
Onco Targets Ther; 2020; 13():337-349. PubMed ID: 32021279
[TBL] [Abstract][Full Text] [Related]
14. Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth.
Chen M; Zhao M; Hou Y; Zhu B
Mol Cell Biochem; 2021 Apr; 476(4):1871-1879. PubMed ID: 33475889
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer.
Wang D; Li Z; Yin H
Front Oncol; 2021; 11():751903. PubMed ID: 34868956
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway.
Cai Y; He J; Zhang D
Onco Targets Ther; 2015; 8():2657-64. PubMed ID: 26442763
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
20. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway.
Wang M; Wang L; He X; Zhang J; Zhu Z; Zhang M; Li X
Int J Oncol; 2020 Jan; 56(1):327-336. PubMed ID: 31789385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
